Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 2, 1999, Pages 133-139

  Kaw, Semiko ^a   Hecker, Markus ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Bovine; Coronary heart disease; Derived hyperpolarizing factor; Endothelium; LAD; Menadione; Nitric oxide; Prostacyclin; Superoxide anion

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; BRADYKININ; DICLOFENAC; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; MENADIONE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; POTASSIUM CHLORIDE; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM CHLORIDE; SUPEROXIDE; TETRABUTYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OXIDATIVE STRESS;

EID: 0033001633     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005332     Document Type: Article

References (24)

1. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK (1994) Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91:7583-7587
2. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R (1996) Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94:3341-3347
3. Brandes RP, Behra A, Lebherz C, Böger RH, Bode-Böger SM, Phivthong-Ngam L, Mügge A (1997) N(G)-nitro-L-arginine-and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis 135:49-55
4. Busse R, Fleming I (1996) Endothelial dysfunction in atherosclerosis. J Vasc Res 33:181-194
5. 1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol 123:968-974
6. Cohen RA, Plane F, Najibi S, Huk I, Malinski T, Garland CJ (1997) Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci USA 94:4193-4198
7. Comporti M (1989) Three models of free radical-induced cell injury. Chem Biol Interact 72:1-56
8. Fulton D, McGigg JC, Wolin MS, Kaminski P, Quilley J (1997) Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat. J Pharmacol Exp Ther 280:702-709
9. Garland CJ, Plane F, Kemp BK, Cocks TM (1995) Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 16:23-30
10. Gebremedhin D, Harder DR, Pratt PF, Campbell WB (1998) Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35:274-284
11. + channels in porcine coronary artery smooth muscle cells. J Cardiovasc Pharmacol 32:642-649
12. Hecker M, Bara AT, Bauersachs J, Busse R (1994) Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond) 481:407-414
13. Holzmann S, Kukovetz WR, Windischhofer W, Paschke E, Graier WF (1994) Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc Pharmacol 23:757-756
14. Kaw S, Hecker M (1998) Oxidative stress and EDHF release in coronary arteries (abstract). Pflüger's Arch [Suppl] 435:R75
15. Li P, Zou A, Campbell WB (1997) Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators. Hypertension 29:262-267
16. + channels. Circ Res 83:501-507
17. Mombouli JV, Vanhoutte P (1997) Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci 18:252-256
18. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551
19. Parsaee H, McEwan JR, Joseph S, MacDermot J (1992) Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells. Br J Pharmacol 107:1013-1019
20. Popp R, Bauersachs J, Hecker M, Fleming I, Busse R (1996) A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesised by porcine coronary endothelial cells. J Physiol (Lond) 497:699-709
21. Popp R, Fleming I, Busse R (1998) Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor. A modulator of arterial compliance. Circ Res 82:696-703
22. Reif DW, McCreedy SA (1995) N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch Biochem Biophys 320:170-176
23. Schrör K, Sauerland S, Kuhn A, Rosen R (1980) Different sensitivities of prostaglandin-cyclooxygenases in blood platelets and coronary arteries against non-steroidal antiinflammatory drugs. Naunyn-Schmiedeberg's Arch Pharmacol 313:69-76
24. Zou MH, Ullrich V (1996) Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 382:101-104